Mai-Li Liu
Overview
Explore the profile of Mai-Li Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang B, He B, Ruan X, Zhu J, Hu R, Wang J, et al.
Mil Med Res
. 2022 Sep;
9(1):51.
PMID: 36131323
Background: Tumor cell heterogeneity mediated drug resistance has been recognized as the stumbling block of cancer treatment. Elucidating the cytotoxicity of anticancer drugs at single-cell level in a high-throughput way...
2.
Liu Z, Gong Z, Jiang W, Yang J, Zhu W, Guo D, et al.
Elife
. 2015 Jun;
4.
PMID: 26090905
A polyubiquitin comprises multiple covalently linked ubiquitins and recognizes myriad targets. Free or bound to ligands, polyubiquitins are found in different arrangements of ubiquitin subunits. To understand the structural basis...
3.
Xing Q, Huang P, Yang J, Sun J, Gong Z, Dong X, et al.
Angew Chem Int Ed Engl
. 2014 Aug;
53(43):11501-5.
PMID: 25131700
Proteins interact with each other to fulfill their functions. The importance of weak protein-protein interactions has been increasingly recognized. However, owing to technical difficulties, ultra-weak interactions remain to be characterized....
4.
Chen Z, Zeng D, Hu Y, He Y, Pan N, Ding J, et al.
PLoS One
. 2012 Apr;
7(4):e35154.
PMID: 22511981
Background: Although the basic scorpion K(+) channel toxins (KTxs) are well-known pharmacological tools and potential drug candidates, characterization the acidic KTxs still has the great significance for their potential selectivity...
5.
Liao W, Fan M, Yang Y, Yang W, Li L, Liu M
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2010 Dec;
19(3):209-12.
PMID: 21189575
Aim: To investigate the effects of Angelica sinensis injection on the neuronal metabolites and blood flow speed within reperfusion in the ischemic cerebral injury of rats. Methods: Sixty-nine male Sprague...
6.
Jiang Y, Lu X, Chen H, Mao S, Liu M, Luo P, et al.
J Phys Chem B
. 2009 May;
113(24):8357-61.
PMID: 19462938
Three kinds of conventional surfactants, namely, two nonionic surfactants [polyethylene glycol (23) lauryl ether (Brij-35) and Triton X-100 (TX-100)], one cationic surfactant [n-tetradecyltrimethyl ammonium bromide (TTAB)], and an anionic surfactant...
7.
Yin S, Jiang L, Yi H, Han S, Yang D, Liu M, et al.
J Proteome Res
. 2008 Oct;
7(11):4890-7.
PMID: 18937510
The low selectivity of Kv1 peptide inhibitors for specific isoforms makes them poor candidates for the development of theraputics. Using combined approaches, we showed that the Kv1 turret is the...
8.
Jiang Y, Chen H, Cui X, Mao S, Liu M, Luo P, et al.
Langmuir
. 2008 Feb;
24(7):3118-21.
PMID: 18266397
Two quaternary ammonium Gemini surfactant series, 12-s-12, ([C(12)H(25)N+ (CH(3))(2)](2)(CH(2))(s).(2)Br(-)) and 14-s-14 ([C(14)H(29)N(+)(CH(3))(2)](2)(CH(2))(s).(2)Br(-)), where s = 2, 3, and 4, have been studied by the use of (1)H NMR in aqueous...
9.
Yan G, Liu M, Li L
Bioconjug Chem
. 2005 Jul;
16(4):967-71.
PMID: 16029038
Both diethylenetriaminepentaacetic acid (DTPA) and sulfadiazine (SD) were incorporated into polyaspartamides with different side chains, including poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide] (PHEA), poly-alpha,beta-[N- (3-hydroxypropyl)-L-aspartamide] (PHPA), poly-alpha,beta-[N-(2-aminoethy1)-L-aspartamide] (PAEA), poly-alpha,beta-[N-(4-aminobuty1)-L-aspartamide] (PABA), and poly-alpha,beta-[N-(6-aminohexyl)-L-aspartamide] (PAHA). The polyaspartamide...
10.
Yan G, Hu B, Liu M, Li L
J Pharm Pharmacol
. 2005 Apr;
57(3):351-7.
PMID: 15807991
Diethylenetriaminepentaacetic acid (DTPA) and pyridoxamine (PM) were incorporated into the amine groups on the surface of ammonia-core poly(amidoamine) dendrimers (PAMAM, Generation 2.0-5.0) to obtain dendritic ligands. These dendritic ligands were...